Analysts have been eager to weigh in on the Healthcare sector with new ratings on Intuitive Surgical (ISRG – Research Report), Regulus (RGLS – Research Report) and Kura Oncology (KURA – Research Report). Intuitive Surgical (ISRG) In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Intuitive Surgical, with a price target of $360.00. The company's shares closed last Thursday at $292.73. According to TipRanks.com, Zimmerman is a 5-star analyst with an average return of -17.7% and a 21.3% success rate. Pantginis covers the Healthcare sector, focusing on stocks such as Applied Genetic Technologies, Lineage Cell Therapeutics, and Actinium Pharmaceuticals.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-intuitive-surgical-isrg-regulus-rgls-and-kura-oncology-kura?utm_source=advfn.com&utm_medium=referral
Regulus Therapeutics (NASDAQ:RGLS)
Historical Stock Chart
From Sep 2022 to Oct 2022 Click Here for more Regulus Therapeutics Charts.
Regulus Therapeutics (NASDAQ:RGLS)
Historical Stock Chart
From Oct 2021 to Oct 2022 Click Here for more Regulus Therapeutics Charts.